Onconetix Inc ONCO 深 沪
等待开盘 05-14 09:30:00 美东时间
0.387
-0.021
-5.10%
华盛通- 最 高0.41
- 今 开0.4078
- 成交量 62.83万股
- 最 低 0.38
- 昨 收 0.4078
- 总市值 26.82万
- 52周最高 36.125
- 市盈率 静 --
- 换手率 90.68%
- 52周最低 0.36
- 委 比 50.00%
- 总股本 69.29万
- 历史最高 1545300.00
- 量 比 0.63
- 振 幅 7.36%
- 历史最低 0.36
- 每 手 1
- 风险率 9.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Onconetix Q1 EPS $(6.71) Up From $(225.25) YoY, Sales $21.457K Down From $101.630K YoY
Onconetix (NASDAQ:ONCO) reported quarterly losses of $(6.71) per share. This is a 97.02 percent increase over losses of $(225.25) per share from the same period last year. The company reported $21.457 thousand in sales
05-13 21:48
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Virax Biolabs Group (NASDAQ:VRAX) stock increased by 56.4% to $0.16 du...
04-14 01:05
Onconetix Announces Realbotix Delivers Its First Vinci-Equipped Humanoid Robot To Ericsson
Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the "Company") is providing the following summary of a press release issued by Realbotix Corp., parent of Realbotix LLC ("Realbotix"), the target of Onconetix's previously
04-09 20:35
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Axe Compute (NASDAQ:AGPU) shares increased by 23.0% to $4.38 during We...
04-02 05:05
Onconetix Appoints David White CEO, Effective March 18, Succeeding Interim CEO Karina Fedasz
Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the "Company") today announced the appointment of David White as Chief Executive Officer, effective March 18, 2026, and the appointment of Sammy Dorf as a member of the
03-31 20:31
What's Going On With Onconetix Shares On Friday?
Onconetix (ONCO) shares surge 71% premarket following the Realbotix acquisition update and 1-for-5 reverse split.
03-27 20:15
Market-Moving News for March 27th
U: 18% | Unity Software shares are trading higher after the company issued preliminary Q1 2026 revenue guidance that exceeded its earlier outlook AZN: 3% | AstraZeneca shares are trading higher after the
03-27 19:18
Onconetix Announces 1-For-5 Reverse Stock Split, Effective March 25
Onconetix, Inc. (NASDAQ: ONCO) ("Onconetix" or the "Company"), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology,
03-23 20:36
Onconetix approves 1-for-5 reverse stock split effective March 25, 2026
Onconetix approves 1-for-5 reverse stock split effective March 25, 2026 Onconetix approved a 1-for-5 reverse stock split effective at 12:01 a.m. ET on March 25, 2026. Trading is expected to begin on a split-adjusted basis at the market open on March 25, 2026. Each 5 outstanding common shares will be
03-23 20:33
